Literature DB >> 33007777

Neurocognitive and functional heterogeneity in depressed youth.

Erica B Baller1, Antonia N Kaczkurkin1,2, Aristeidis Sotiras3,4,5, Azeez Adebimpe1, Danielle S Bassett1,6,7,8,9,10,11, Monica E Calkins1,12, Ganesh B Chand3,5, Zaixu Cui1, Raquel E Gur1,3,9,12, Ruben C Gur1,3,12, Kristin A Linn13, Tyler M Moore1,12, David R Roalf1,12, Erdem Varol3,5, Daniel H Wolf1,5,12, Cedric H Xia1, Christos Davatzikos3,5, Theodore D Satterthwaite14,15,16.   

Abstract

Depression is a common psychiatric illness that often begins in youth, and is sometimes associated with cognitive deficits. However, there is significant variability in cognitive dysfunction, likely reflecting biological heterogeneity. We sought to identify neurocognitive subtypes and their neurofunctional signatures in a large cross-sectional sample of depressed youth. Participants were drawn from the Philadelphia Neurodevelopmental Cohort, including 712 youth with a lifetime history of a major depressive episode and 712 typically developing (TD) youth matched on age and sex. A subset (MDD n = 368, TD n = 200) also completed neuroimaging. Cognition was assessed with the Penn Computerized Neurocognitive Battery. A recently developed semi-supervised machine learning algorithm was used to delineate neurocognitive subtypes. Subtypes were evaluated for differences in both clinical psychopathology and brain activation during an n-back working memory fMRI task. We identified three neurocognitive subtypes in the depressed group. Subtype 1 was high-performing (high accuracy, moderate speed), Subtype 2 was cognitively impaired (low accuracy, slow speed), and Subtype 3 was impulsive (low accuracy, fast speed). While subtypes did not differ in clinical psychopathology, they diverged in their activation profiles in regions critical for executive function, which mirrored differences in cognition. Taken together, these data suggest disparate mechanisms of cognitive vulnerability and resilience in depressed youth, which may inform the identification of biomarkers for prognosis and treatment response.

Entities:  

Mesh:

Year:  2020        PMID: 33007777      PMCID: PMC8027806          DOI: 10.1038/s41386-020-00871-w

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  48 in total

1.  Neuropsychological clustering highlights cognitive differences in young people presenting with depressive symptoms.

Authors:  Daniel F Hermens; M Antoinette Redoblado Hodge; Sharon L Naismith; Manreena Kaur; Elizabeth Scott; Ian B Hickie
Journal:  J Int Neuropsychol Soc       Date:  2011-01-04       Impact factor: 2.892

2.  Educating Religious Leaders Increases Male Circumcision Rates in Tanzania.

Authors:  M J Friedrich
Journal:  JAMA       Date:  2017-04-18       Impact factor: 56.272

Review 3.  A meta-analysis of cognitive functions in children and adolescents with major depressive disorder.

Authors:  Stefanie Wagner; Carmen Müller; Isabella Helmreich; Michael Huss; André Tadić
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-05-29       Impact factor: 4.785

4.  Neurocognitive impairment in adolescent major depressive disorder: state vs. trait illness markers.

Authors:  Fadi T Maalouf; David Brent; Luke Clark; Lucy Tavitian; Rebecca Munnell McHugh; Barbara J Sahakian; Mary L Phillips
Journal:  J Affect Disord       Date:  2011-05-26       Impact factor: 4.839

5.  Prevalence and Treatment of Depression, Anxiety, and Conduct Problems in US Children.

Authors:  Reem M Ghandour; Laura J Sherman; Catherine J Vladutiu; Mir M Ali; Sean E Lynch; Rebecca H Bitsko; Stephen J Blumberg
Journal:  J Pediatr       Date:  2018-10-12       Impact factor: 4.406

6.  Intergenerational Socioeconomic Mobility and Adult Depression: The CONSTANCES Study.

Authors:  Maria Melchior; Abdelkrim Ziad; Emilie Courtin; Marcel Goldberg; Marie Zins; Judith van der Waerden
Journal:  Am J Epidemiol       Date:  2018-02-01       Impact factor: 4.897

7.  Adverse childhood experiences and the risk of depressive disorders in adulthood.

Authors:  Daniel P Chapman; Charles L Whitfield; Vincent J Felitti; Shanta R Dube; Valerie J Edwards; Robert F Anda
Journal:  J Affect Disord       Date:  2004-10-15       Impact factor: 4.839

8.  Sequential treatment with fluoxetine and relapse--prevention CBT to improve outcomes in pediatric depression.

Authors:  Betsy D Kennard; Graham J Emslie; Taryn L Mayes; Paul A Nakonezny; Jessica M Jones; Aleksandra A Foxwell; Jessica King
Journal:  Am J Psychiatry       Date:  2014-10       Impact factor: 18.112

Review 9.  The genetics of major depression.

Authors:  Jonathan Flint; Kenneth S Kendler
Journal:  Neuron       Date:  2014-02-05       Impact factor: 17.173

Review 10.  Characterizing neurocognitive impairment in young people with major depression: state, trait, or scar?

Authors:  Kelly Allott; Caroline A Fisher; Gunther Paul Amminger; Joanne Goodall; Sarah Hetrick
Journal:  Brain Behav       Date:  2016-07-21       Impact factor: 2.708

View more
  2 in total

1.  Effects and Mechanisms of Synaptotagmin-7 in the Hippocampus on Cognitive Impairment in Aging Mice.

Authors:  Yaru Xie; Kaining Zhi; Xianfang Meng
Journal:  Mol Neurobiol       Date:  2021-08-17       Impact factor: 5.590

2.  Developmental coupling of cerebral blood flow and fMRI fluctuations in youth.

Authors:  Erica B Baller; Alessandra M Valcarcel; Azeez Adebimpe; Aaron Alexander-Bloch; Zaixu Cui; Ruben C Gur; Raquel E Gur; Bart L Larsen; Kristin A Linn; Carly M O'Donnell; Adam R Pines; Armin Raznahan; David R Roalf; Valerie J Sydnor; Tinashe M Tapera; M Dylan Tisdall; Simon Vandekar; Cedric H Xia; John A Detre; Russell T Shinohara; Theodore D Satterthwaite
Journal:  Cell Rep       Date:  2022-03-29       Impact factor: 9.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.